Ad is loading...
MVCAX
Price
$35.14
Change
-$0.23 (-0.65%)
Updated
Nov 15 closing price
NCBVX
Price
$20.88
Change
-$0.14 (-0.67%)
Updated
Nov 15 closing price
Ad is loading...

MVCAX vs NCBVX

Header iconMVCAX vs NCBVX Comparison
Open Charts MVCAX vs NCBVXBanner chart's image
MFS Mid Cap Value A
Price$35.14
Change-$0.23 (-0.65%)
VolumeN/A
CapitalizationN/A
PGIM Quant Solutions Mid-Cap Val C
Price$20.88
Change-$0.14 (-0.67%)
VolumeN/A
CapitalizationN/A
MVCAX vs NCBVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MVCAX vs. NCBVX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MVCAX is a Buy and NCBVX is a Buy.

FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 17.9B vs. NCBVX (182M). NCBVX pays higher dividends than MVCAX: NCBVX (1.47) vs MVCAX (1.16). MVCAX was incepted earlier than NCBVX: MVCAX (23 years) vs NCBVX (26 years). NCBVX is a more actively managed with annual turnover of: 70.00 vs. MVCAX (19.00). MVCAX (1000) and NCBVX (1000) have matching initial minimum investment requirements. NCBVX (27.09) and MVCAX (26.84) have marching annual gain over last year. MVCAX return over 5 years is better than : 49.25 vs. NCBVX (42.19).
MVCAXNCBVXMVCAX / NCBVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years26 years-
Gain YTD17.80114.161126%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets17.9B182M9,835%
Annual Yield % from dividends1.161.4779%
Returns for 1 year26.8427.0999%
Returns for 3 years8.5511.0378%
Returns for 5 years49.2542.19117%
Returns for 10 years78.6418.00437%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVRI13.37-0.05
-0.37%
Everi Holdings
IEX227.83-1.56
-0.68%
IDEX Corp
TTOO0.50-0.02
-4.42%
T2 Biosystems
APLS26.27-1.79
-6.38%
Apellis Pharmaceuticals
NKTR1.07-0.10
-8.55%
Nektar Therapeutics